| Literature DB >> 35979987 |
Yong Liu1, Peiheng He1, Xing Li1, Minghao Liu1, Weizhi Chen1, Dongliang Xu1.
Abstract
OBJECTIVE: The bone mass around the prosthesis plays an important role in the stability of the prosthesis. This study aimed to assess the effect of postoperative activity on bone mineral density (BMD) in the proximal tibia 5 years after total knee arthroplasty (TKA). To provide a scientific guidance for postoperative functional exercise.Entities:
Keywords: Activity level; Bone loss; Bone mineral density; Prosthetic loosening; Total knee arthroplasty
Mesh:
Year: 2022 PMID: 35979987 PMCID: PMC9483071 DOI: 10.1111/os.13386
Source DB: PubMed Journal: Orthop Surg ISSN: 1757-7853 Impact factor: 2.279
Fig. 1(A) Schematic diagram of lower limb x‐ray photography, the patients' knee joint was controlled in a neutral position by black bind to reduce errors caused by differences in the position of the knee. Knee flexion was minimized by fixing the tibial tubercle at the lower end of the knee. Rotation was controlled by fixing the heel and the first and second toes. (B) rBMD was measured at 3 regions of interest around the tibial component on X‐ray film, R1: medial metaphyseal region, R2: lateral metaphyseal region, R3: diaphyseal region. Regions a and f measured the gray values of air and metal in the femoral prosthesis, respectively, to adjust the bone density. The measured area avoided cement, cortical bone, and the fibula head
Fig. 2Flow diagram of the study. LA, low activity; MA, medium activity; HA, high activity
Demographic and clinical subject characteristics
| Variables | LA group ( | MA group ( | HA group ( |
|
|
|---|---|---|---|---|---|
| Gender (male/female) | M5/F28 | M10/F41 | M5/F21 | – | – |
| Age (years) | 66.7 (64–69) | 66.1 (63–68) | 67.4 (65–69) | 0.29 | 0.75 |
| BMI (kg/m2) | 27.3 (26.0–28.7) | 26.0 (25.0–27.0) | 26.9 (25.8–28.1) | 1.68 | 0.19 |
| Disease Course (years) | 9.5 (7.7–11.4) | 10.1 (8.6–11.7) | 10.0 (8.3–11.7) | 0.13 | 0.87 |
| Operation time (min) | 157.3 (149.1–165.5) | 158.6 (153.7–163.5) | 147.3 (138.9–155.7) | 6.26 | 0.06 |
| Blood loss (mL) | 81.5 (71.7–91.3) | 83.0 (75.8–90.3) | 81.2 (71.1–91.2) | 0.10 | 0.94 |
| Hospital stay (days) | 11.3 (10.5–12.1) | 11.7 (10.9–12.4) | 11.9 (10.3–13.4) | 0.28 | 0.75 |
| Preoperative rBMD | 151.7 (147.0–156.4) | 153.6 (150.2–157.1) | 153.6 (150.2–157.1) | 0.34 | 0.72 |
| Preoperative ROM (°) | 169.0 (167.2–170.8) | 170.1 (168.9–171.4) | 169.0 (167.2–170.8) | 0.95 | 0.45 |
| Preoperative KSS score | |||||
| clinical score (point) | 48.9 (44.3–53.5) | 51.1 (47.0–55.1) | 52.3 (44.8–59.8) | 0.38 | 0.68 |
| function score (point) | 31.6 (25.2–38.1) | 27.0 (22.1–31.8) | 31.5 (22.9–39.9) | 0.85 | 0.43 |
| VAS (point) | 6.27 (5.0–7.0) | 6.18 (5.0–7.0) | 6.35 (5.8–7.0) | 0.25 | 0.77 |
Values are presented as mean (95% confidence interval) or numbers.
Abbreviations: BMI, body mass index; HA, high activity; KSS, Knee Society Score; LA, low activity; MA, medium activity; rBMD, relative bone mineral density; ROM, range of motion; VAS, visual analogue scale.
Fig. 3All 110 patients' average rBMD change curve in R1, R2 and R3 within 5 follow‐up years. The rBMD decreased over time significantly and the most severe at medial region (R1)
Fig. 4Figures showed the effect of activity level on medial rBMD. A: shows the average rBMD change curve over time. The average rBMD of LA MA and HA groups declined over time but the rBMD of MA group was significantly higher than LA and HA groups at 1 and 3 years. There was no significant difference between LA group and HA group. B: shows the Δ BMD (%) among LA MA and HA groups at 1 year and 3 years. The Δ BMD (%) of MA group was significantly lower than LA and HA group both at 1 year and 3 years. There was no significant difference between LA and HA groups. *: P < 0.05, **: P < 0.01, ***: P < 0.001
The rBMD of 3 ROIs at 1 year, 3 years and 5 years
| ROIs | Groups |
| baseline | 3 months | 1 year | 3 years | 5 years | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| rBMD | F |
| rBMD | F |
| rBMD | F |
| rBMD | F |
| rBMD | F |
| |||
| R1 | LA | 33 | 120.7 ± 7.6 | 0.59 | 110.8 ± 7.46 | 0.94 | 106.1 ± 6.69 |
| 101.2 ± 6.76 |
| 101.8 ± 6.36 | 0.12 | |||||
| MA | 51 | 119.6 ± 5.4 | 0.53 | 110.4 ± 5.8 | 0.06 | 108.9 ± 5.2 | 4.24 | 108.5 ± 6.0 | 12.23 | 104.7 ± 6.3 | 2.15 | ||||||
| HA | 26 | 121.0 ± 6.8 | 110.9 ± 7.3 | 105.4 ± 5.2 | 103.0 ± 6.8 | 104.9 ± 8.3 | |||||||||||
| R2 | LA | 33 | 121.3 ± 6.9 | 0.21 | 115.7 ± 8.0 | 0.40 | 114.0 ± 8.9 | 0.14 | 112.8 ± 10.3 | 0.51 | 112.3 ± 7.8 | 0.58 | |||||
| MA | 51 | 120.1 ± 5.5 | 1.31 | 114.3 ± 6.5 | 0.91 | 112.6 ± 9.8 | 2.02 | 112.8 ± 9.2 | 0.68 | 110.7 ± 6.9 | 0.55 | ||||||
| HA | 26 | 122.6 ± 5.3 | 116.3 ± 5.5 | 117.1 ± 8.6 | 115.4 ± 10.6 | 112.2 ± 8.6 | |||||||||||
| R3 | LA | 33 | 133.9 ± 8.1 | 0.28 | 132.1 ± 7.6 | 0.99 | 132.0 ± 7.8 | 0.16 | 131.6 ± 6.7 | 0.41 | 129.4 ± 6.1 | 0.55 | |||||
| MA | 51 | 132.9 ± 8.4 | 1.28 | 131.9 ± 8.0 | 0.01 | 130.8 ± 7.6 | 1.88 | 130.7 ± 8.3 | 0.89 | 128.9 ± 7.8 | 0.59 | ||||||
| HA | 26 | 136.0 ± 7.9 | 132.1 ± 8.1 | 134.4 ± 7.9 | 133.1 ± 7.5 | 130.8 ± 7.2 |
Abbreviations: HA, high activity; LA, low activity; MA, medium activity; ROIs, range of interests; rBMD, relative bone mineral density. Bold indicates highlight the p value.
The rBMD changes (ΔBMD (%)) of 3 ROIs at 1 year, 3 years and 5 years
| ROIs | Group | 1 year | 3 years | 5 years | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ΔBMD (%) | F |
| ΔBMD (%) | F |
| ΔBMD (%) | F |
| ||
| R1 | LA | 11.92 ± 5.49 |
6.02 |
| 16.04 ± 4.79 |
24.5 |
| 15.44 ± 6.06 |
2.82 | 0.06 |
| MA | 8.75 ± 5.36 | 9.11 ± 5.11 | 12.36 ± 5.29 | |||||||
| HA | 12.70 ± 5.21 | 14.82 ± 4.26 | 13.14 ± 6.66 | |||||||
| R2 | LA | 5.97 ± 6.12 |
0.53 | 0.59 | 6.96 ± 6.97 |
1.19 | 0.30 | 7.27 ± 6.05 |
1.11 | 0.33 |
| MA | 6.15 ± 7.52 | 5.94 ± 7.33 | 7.70 ± 5.21 | |||||||
| HA | 4.38 ± 6.66 | 5.81 ± 8.06 | 8.39 ± 7.26 | |||||||
| R3 | LA | 1.22 ± 4.86 |
0.06 | 0.94 | 1.55 ± 3.99 |
0.13 | 0.87 | 3.11 ± 5.01 |
0.32 | 0.72 |
| MA | 1.47 ± 3.96 | 1.56 ± 4.61 | 2.85 ± 4.65 | |||||||
| HA | 1.16 ± 3.61 | 2.05 ± 3.98 | 3.75 ± 4.17 | |||||||
Abbreviations: HA, high activity; LA, low activity; MA, medium activity; ROIs, range of interests; rBMD, relative bone mineral density. Bold indicates highlight the p value.
Clinical outcomes at the endpoint of the study
| LA Group ( | MA Group ( | HA Group ( |
|
| |
|---|---|---|---|---|---|
| KSS | |||||
| Clinical scores (point) | 92.45 ± 6.03 | 91.73 ± 6.78 | 93.69 ± 5.24 | 0.86 | 0.42 |
| Functional scores (point) | 89.09 ± 3.41 | 90.00 ± 4.70 | 89.81 ± 4.99 | 0.44 | 0.65 |
| VAS (point) | 3.00 ± 1.17 | 2.63 ± 0.77 | 1.65 ± 0.79 | 16.49 | <0.001 |
| ROM (°) | 102.90 ± 8.48 | 110.20 ± 6.78 | 111.90 ± 9.17 | 11.92 | <0.001 |
Abbreviations: HA, high activity; KSS, Knee Society Score; LA, low activity; MA, medium activity; ROM, range of motion; VAS, visual analogue scale.